Tingbo Liang Selected Research

Tingbo Liang Research Topics

Disease

119	Neoplasms (Cancer) 05/2024 - 05/2013
45	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 12/2014
34	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 07/2007
27	Adenocarcinoma 04/2024 - 09/2015
16	Carcinogenesis 05/2024 - 02/2013
16	COVID-19 10/2023 - 01/2020
10	Hypoxia (Hypoxemia) 05/2024 - 05/2013
9	Liver Neoplasms (Liver Cancer) 04/2024 - 08/2019
9	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2016
9	Infections 01/2023 - 01/2016
7	Bites and Stings (Sting) 04/2024 - 01/2022
5	Necrosis 03/2024 - 01/2021
5	End Stage Liver Disease 11/2023 - 09/2020
5	Inflammation (Inflammations) 01/2021 - 03/2016
5	Pancreatic Fistula (Pancreatic Fistulas) 01/2020 - 01/2016
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 03/2009
4	Fibrosis (Cirrhosis) 02/2023 - 11/2016
4	Hemorrhage 01/2022 - 01/2005
4	Pneumonia (Pneumonitis) 01/2022 - 01/2020
4	Liver Diseases (Liver Disease) 01/2020 - 02/2002
3	Disease Progression 10/2023 - 01/2017
3	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2016
3	Reinfection 02/2006 - 02/2002
2	Pathologic Constriction (Stenosis) 04/2024 - 01/2019
2	Fever (Fevers) 11/2023 - 01/2020
2	Cytokine Release Syndrome 09/2023 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2017
2	Cholangiocarcinoma 01/2023 - 01/2021
2	Starvation 12/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 12/2022 - 11/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2013

Drug/Important Bio-Agent (IBA)

19	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
11	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2016
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2002
8	InterferonsIBA 04/2024 - 01/2014
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2014
8	Gemcitabine FDA Link 01/2023 - 09/2015
7	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 04/2002
7	folfirinoxIBA 11/2023 - 04/2016
7	AntigensIBA 09/2023 - 07/2014
7	Phosphotransferases (Kinase)IBA 01/2023 - 01/2018
6	sintilimabIBA 08/2023 - 01/2020
5	EnzymesIBA 01/2023 - 01/2020
4	Messenger RNA (mRNA)IBA 03/2024 - 11/2016
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2020
4	Programmed Cell Death 1 ReceptorIBA 07/2023 - 01/2020
4	Oxygen (Dioxygen)IBA 02/2023 - 12/2020
4	Therapeutic UsesIBA 01/2023 - 09/2015
4	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020
4	LigandsIBA 01/2023 - 11/2021
4	CateninsIBA 01/2023 - 05/2013
4	CytokinesIBA 01/2023 - 02/2019
4	Peptides (Polypeptides)IBA 02/2022 - 01/2019
4	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2016
4	Proto-Oncogene Proteins c-metIBA 12/2020 - 01/2020
4	OSI 027IBA 10/2020 - 09/2015
3	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2024 - 01/2018
3	UbiquitinIBA 05/2024 - 01/2018
3	B7-H1 AntigenIBA 04/2024 - 01/2021
3	LipidsIBA 02/2024 - 01/2023
3	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2021
3	Ubiquitin-Specific ProteasesIBA 01/2024 - 11/2018
3	AntibodiesIBA 11/2023 - 11/2021
3	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2023
3	Cell-Free Nucleic AcidsIBA 09/2023 - 01/2019
3	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 01/2017
3	mRNA VaccinesIBA 01/2023 - 01/2021
3	Lamivudine (Epivir)FDA Link 02/2006 - 02/2002
2	Fructose-BisphosphataseIBA 04/2024 - 03/2024
2	Histone Deacetylase InhibitorsIBA 04/2024 - 07/2013
2	Histones (Histone)IBA 04/2024 - 01/2008
2	lenvatinibIBA 04/2024 - 03/2022
2	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2017
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 03/2024 - 01/2022
2	CalciumIBA 02/2024 - 03/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 11/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2023 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 08/2023 - 02/2006
2	Tumor Biomarkers (Tumor Markers)IBA 07/2023 - 01/2023
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2023 - 01/2023
2	Hyaluronic Acid (Hyaluronan)IBA 06/2023 - 01/2023
2	Capsules (Microcapsules)IBA 02/2023 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 12/2020
2	AlbuminsIBA 01/2023 - 03/2010
2	VaccinesIBA 01/2023 - 01/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2022
2	CalcineurinIBA 01/2022 - 01/2021
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2022
2	LTX-315IBA 01/2022 - 01/2022
2	Neutralizing AntibodiesIBA 11/2021 - 01/2020

Therapy/Procedure

49	Therapeutics 05/2024 - 02/2006
32	Immunotherapy 04/2024 - 01/2014
26	Liver Transplantation 04/2024 - 02/2002
19	Drug Therapy (Chemotherapy) 11/2023 - 12/2014
6	Pancreaticoduodenectomy 01/2020 - 01/2016
4	Transplantation 11/2023 - 01/2018
4	Neoadjuvant Therapy 11/2023 - 07/2017
4	Lung Transplantation 01/2022 - 01/2020
3	Hepatectomy 07/2023 - 01/2021
2	Autologous Transplantation 12/2023 - 11/2023